Seeking Alpha

ImmunoCellular Therapeutics (IMUC): Q2 EPS loss of $0.16 misses by $0.07. Net loss $6.5M. Ends...

ImmunoCellular Therapeutics (IMUC): Q2 EPS loss of $0.16 misses by $0.07. Net loss $6.5M. Ends quarter with $11.3M in cash, sufficient to fund next 12 months of operations. Shares +4.1%. (PR)

Check out Seeking Alpha’s new Earnings Center »

Comments (1)
  • Deut28
    , contributor
    Comments (25) | Send Message
     
    you cant miss EPS, when are not really making any money yet. At this point share price gyrations are based on rumours and hype of ICT 107 trial
    15 Aug 2012, 10:41 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs